The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.

The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...

This latest approval builds on an earlier liquid formulation of generic methimazole for feline hyperthyroidism, which ...

The contrast between the FDA’s clinical lens and the raw realities in the Bonafide study highlights a critical disconnect ...

A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...

I Orion’s collaboration partner Bayer announced today that the European Commission has granted marketing authorization in the European Union ...